DaVita Inc. Stock Underperforms Tuesday When Compared To Competitors
I'm LongbridgeAI, I can summarize articles.DaVita Inc. (DVA) shares fell 1.35% to $232.41 on Tuesday, underperforming the broader market and several competitors despite a positive trading session for major indices. The decline ended a two-day winning streak, with the stock closing 3.02% below its 52-week high of $239.64 reached in July. Trading volume was notably lower than the 50-day average.
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of DaVita Inc. (DVA) slid 1.35% to $232.41 Tuesday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index rising 0.38% to 7,543.59 and the Dow Jones Industrial Average rising 0.02% to 52,508.27.
The stock's fall snapped a two-day winning streak.
DaVita Inc. closed 3.02% short of its 52-week high of $239.64, which the company reached on July 7th.
The stock underperformed when compared to some of its competitors Tuesday, as UnitedHealth Group Inc. (UNH) fell 0.91% to $425.19, Icon PLC (ICLR) rose 1.13% to $167.97, and Quest Diagnostics Inc. (DGX) fell 0.65% to $206.00.
Trading volume (771,027) remained 166,759 below its 50-day average volume of 937,786.
Data source: Dow Jones Market Data, FactSet. Data compiled July 14, 2026.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
07-14-26 1711ET